Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma
CONCLUSIONS: PKCδ is an enhanced biomarker for the diagnosis of HCC that compensates for the drawbacks of conventional markers.PMID:38361436 | DOI:10.1080/1354750X.2024.2312990
Source: Biomarkers - Category: Research Authors: Chika Nakagawa Tsunekazu Oikawa Kohji Yamada Akihito Tsubota Chisato Saeki Kuniko Katagiri Naoko Tago Hiroshi Kamioka Kaoru Ueda Koichiro Haruki Kenei Furukawa Masanori Nakano Yuichi Torisu Toru Ikegami Kiyotsugu Yoshida Masayuki Saruta Source Type: research
More News: Cancer & Oncology | Carcinoma | Coumadin | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Research | Study | Urology & Nephrology | Warfarin